PCM
CELG

Price Capital Management’s Celgene Corp CELG Stock Holding History

Price Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-9,025
Closed -$717K – 215
2018
Q2 		$717K Buy
+9,025
New +$749K 0.35% 72
2015
Q2 		– Sell
-2,051
Closed -$236K – 299
2015
Q1 		$236K Buy
+2,051
New +$245K 0.15% 180

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Price Capital Management's CELG Position: Q3 2018 in Review

Price Capital Management sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 9,025 shares — an estimated $717K sold.

Price Capital Management first reported a position in CELG in Q1 2015 and held it in 2 quarters. The position peaked at $717K in Q2 2018. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Price Capital Management reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Price Capital Management sold 9,025 Celgene Corp shares in Q3 2018, an estimated $717K.
  • Price Capital Management first reported a position in Celgene Corp in Q1 2015 and held it in 2 quarters.
  • Price Capital Management's Celgene Corp position peaked at $717K in Q2 2018.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Price Capital Management's 13F filing for Q3 2018, filed 29 Oct 2018.